Cancer drug company founder and CEO Brian Slingerland will give the keynote address at the Pamplin College of Business commencement ceremony on Friday, May 13, at 3:30 p.m. at Cassell Coliseum.
Slingerland, an alumnus who received a bachelor’s degree in finance in 2000, co-founded Stemcentrx, a biotechnology company in San Francisco that is doing research to develop new types of cancer treatments.
Stemcentrx, which has five cancer drugs in human clinical trials, is being acquired by drugmaker AbbVie Inc. in a $10.2 billion deal that is one of the 10 biggest biotechnology deals in history.
Slingerland has served as president of Virginia Tech’s Bay Area alumni chapter for several years. He served a three-year term on the Alumni Association board of directors. He was Pamplin’s 2009 Outstanding Recent Alumnus.
To watch Brian Slingerland’s speach at the Spring 2016 Commencement, you may tune in on May 13 at 3:30 p.m.